Table 3.
Number of patients with WSLs in the study and control groups in subsequent examinations.
| Group | Examination | n (%) | T0 versus T4 |
|---|---|---|---|
| P | |||
| I | T0 | 0 (0.00) | 0.01777 |
| T1 | 2 (6.67) | ||
| T2 | 5 (16.67) | ||
| T3 | 5 (16.67) | ||
| T4 | 5 (16.67) | ||
| II | T0 | 0 (0.00) | 0.05590 (NS) |
| T1 | 1 (3.33) | ||
| T2 | 3 (10.00) | ||
| T3 | 3 (10.00) | ||
| T4 | 3 (10.00) | ||
| III | T0 | 0 (0.00) | 0.06478 (NS) |
| T1 | 1 (3.33) | ||
| T2 | 3 (10.00) | ||
| T3 | 3 (10.00) | ||
| T4 | 3 (10.00) | ||
| IV | T0 | 0 (0.00) | 0.05414 (NS) |
| T1 | 0 (0.00) | ||
| T2 | 1 (3.33) | ||
| T3 | 2 (6.67) | ||
| T4 | 2 (6.67) | ||
| K | T0 | 0 (0.00) | 0.00040 |
| T1 | 2 (6.67) | ||
| T2 | 4 (13.33) | ||
| T3 | 7 (23.33) | ||
| T4 | 8 (26.67) |